LIA
CVS icon

Lynx Investment Advisory’s CVS Health CVS Stock Holding History

Lynx Investment Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,194
Closed -$201K – 148
2024
Q3 		$201K Sell
3,194
-243
-7% -$14.2K 0.14% 140
2024
Q2 		$203K Buy
+3,437
New +$215K 0.15% 128

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lynx Investment Advisory's CVS Position: Q4 2024 in Review

Lynx Investment Advisory sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,194 shares — an estimated $201K sold.

Lynx Investment Advisory first reported a position in CVS in Q2 2024 and held it in 2 quarters. The position peaked at $203K in Q2 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Lynx Investment Advisory reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Lynx Investment Advisory sold 3,194 CVS Health shares in Q4 2024, an estimated $201K.
  • Lynx Investment Advisory first reported a position in CVS Health in Q2 2024 and held it in 2 quarters.
  • Lynx Investment Advisory's CVS Health position peaked at $203K in Q2 2024.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Lynx Investment Advisory's 13F filing for Q4 2024, filed 11 Feb 2025.